Advancing Sexual and Reproductive Health and Rights
 
media center

NEWS IN CONTEXT

FDA Proposes New Condom Labeling Guidelines

November 10, 2005

New Rules Could Decrease Condom Use, Put Lives at Risk

In response to political pressure from social conservatives, the U.S. Food and Drug Administration has proposed changes to the existing labels for male condoms to include irrelevant and extraneous information that will only confuse condom users and may even discourage them from using condoms altogether. The FDA, while rightly recommending the label say that condoms used correctly and consistently greatly reduce the risk of pregnancy and HIV, suggests confusing information about the role of condoms in preventing human papilloma virus and genital herpes, and inaccurate information on nonoxynol-9. The proposed rules will be published in the Federal Register on November 14th, which will begin a 90-day comment period during which the public can respond.

Nearly one in five contraceptive users in the United States rely on the male latex condom, which is 98% effective at preventing unwanted pregnancy when used correctly and consistently and is impermeable to even the smallest of sexually transmissible viruses. Yet, opponents are engaged in an active campaign to undermine public confidence in the effectiveness of condoms, putting people’s lives and health at risk.

Click on the links below for more information.

Facts about contraceptive use in the United States

Condoms, contraceptives and nonoxynol-9

Condoms, contraceptives and nonoxynol-9

Campaign to disparage condoms threatens prevention efforts

HPV as a public health and political problem









 

MEDIA UPDATE

Receive brief summaries of upcoming Guttmacher Institute reports with links to full text and other helpful information on the Guttmacher Web site. When new social and political developments affect sexual and reproductive health and rights, this mailing list will also provide you with links to useful background information and contextual data.

enter your e-mail address: